2013-09-28 11:58:43 - New Healthcare market report from Euromonitor International: "Consumer Health in Egypt"
In spite of the Egyptian Revolution of 2011, Egypt maintained its position as the second key player in the pharmaceutical industry, after Turkey. Egypt is expected to witness substantial expansion in the pharmaceutical market for a number of reasons, including continued population growth, the spread of non-communicable diseases (diabetes, cardiovascular diseases,) and the widespread use of generic products, making drugs even more affordable.
Euromonitor International's Consumer Health in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Full Report Details at
Product coverage: Allergy
Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Reasons to Get this Report
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Partial Table of Contents:
CONSUMER HEALTH IN EGYPT
LIST OF CONTENTS AND TABLES
Egypt Remains the Second Largest Pharmaceutical Market in the Region
New Pricing Decree Issued in July 2012 Leaves the Pricing System Unclear
Local Manufacturers Lead Pharmaceutical Industry in Egypt
Holdipharma Leads Distribution Within Pharmaceutical Segment in Egypt
Sales Will Continue To Grow Over the Forecast Period
Key Trends and Developments
High Birth Rate Drives Growth
Black Market Dollars Put Egyptian Economy on A Negative Alert
Regulations Set To Change As Political Atmosphere Settles
Health and Wellness Tourism - An Untapped Opportunity for Egypt
New Framework for A New Social Health Insurance System
Table 1 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 2 Sales of Consumer Health by Category: Value 2007-2012
Table 3 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 4 Consumer Health Company Shares 2008-2012
Table 5 Consumer Health Brand Shares 2009-2012
Table 6 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 7 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 8 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 9 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 1 Research Sources
Amoun Pharmaceutical Industry Co in Consumer Health (egypt)
Summary 2 Amoun Pharmaceutical Industry Co: Key Facts
Summary 3 Amoun Pharmaceutical Industry Co: Operational Indicators
Summary 4 Amoun Pharmaceutical Industry Co: Competitive Position 2012
Egyptian International Pharmaceutical Industries Co Sae (eipico) in Consumer Health (egypt)
Summary 5 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Key Facts
Summary 6 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Operational Indicators
Summary 7 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Competitive Position 2012
Mepaco (arab Co for Pharmaceuticals & Medicinal Plants) in Consumer Health (egypt)
Summary 8 MEPACO (Arab Co For Pharmaceutical & Medicinal Plants): Key Facts
Summary 9 MEPACO (Arab Co For Pharmaceutical & Medicinal Plants): Operational Indicators
Summary 10 MEPACO (Arab Co For Pharmaceutical & Medicinal Plants): Competitive Position 2012
Pharco Pharmaceuticals in Consumer Health (egypt)
Summary 11 Pharco Pharmaceuticals: Key Facts
Summary 12 Pharco Pharmaceuticals: Competitive Position 2012
Full Table of Contents is available at:
About Euromonitor International
Euromonitor International is a world leading independent provider of business intelligence on industries, countries and consumers. Their business intelligence products include award-winning online information databases, market reports and business reference books. Founded in 1972, Euromonitor International is a privately owned company with offices in London, Chicago, Singapore, Shanghai and Vilnius. Euromonitor has a team of over 600 in-country analysts worldwide, giving them a unique capability to deliver high quality and reliable business information. View more research from Euromonitor International at www.fastmr.com/catalog/publishers.aspx?pubid=1009
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.